Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Vascular Surgery
|
November 29, 2011
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication
Eric P Brass, Leslie T Cooper, Roger E Morgan, et al.
Journal of Cardiovascular Pharmacology
|
April 5, 2012
Comparison of the safety, tolerability, and pharmacokinetic profile of a single oral dose of pitavastatin 4 mg in adult subjects with severe renal impairment not on hemodialysis versus healthy adult subjects
Roger E Morgan, Stuart E Campbell, Christine Y Yu, et al.
Clinical Therapeutics
|
July 7, 2014
Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial
Craig A Sponseller, Roger E Morgan, Vladimir A Kryzhanovski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 26, 2012
Effects of steady-state lopinavir/ritonavir on the pharmacokinetics of pitavastatin in healthy adult volunteers
Roger E Morgan, Stuart E Campbell, Kazuhito Suehira, et al.
Clinical Drug Investigation
|
May 15, 2014
Steady-state pharmacokinetics of darunavir/ritonavir and pitavastatin when co-administered to healthy adult volunteers
Christine Y Yu, Stuart E Campbell, Craig A Sponseller, et al.
Cureus
|
April 27, 2026
Data and Safety Monitoring Board Best Practices in Clinical Trials
Gerald L Klein, Roger E Morgan, Melissa Palmer, et al.
Current Medical Research and Opinion
|
December 14, 2011
Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin
Christine Y Yu, Stuart E Campbell, Baojin Zhu, et al.
Journal of Alzheimer'S Disease : JAD
|
April 3, 2026
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
Everard G B Vijverberg, Douglas W Scharre, Michael Woodward, et al.
Cureus
|
October 17, 2025
The Essential Role of Medical Monitors in Clinical Trials
Gerald L Klein, Elizabeth Barabash, Roger E Morgan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Vascular Surgery
|
November 29, 2011
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication
Eric P Brass, Leslie T Cooper, Roger E Morgan, et al.
Journal of Cardiovascular Pharmacology
|
April 5, 2012
Comparison of the safety, tolerability, and pharmacokinetic profile of a single oral dose of pitavastatin 4 mg in adult subjects with severe renal impairment not on hemodialysis versus healthy adult subjects
Roger E Morgan, Stuart E Campbell, Christine Y Yu, et al.
Clinical Therapeutics
|
July 7, 2014
Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial
Craig A Sponseller, Roger E Morgan, Vladimir A Kryzhanovski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 26, 2012
Effects of steady-state lopinavir/ritonavir on the pharmacokinetics of pitavastatin in healthy adult volunteers
Roger E Morgan, Stuart E Campbell, Kazuhito Suehira, et al.
Clinical Drug Investigation
|
May 15, 2014
Steady-state pharmacokinetics of darunavir/ritonavir and pitavastatin when co-administered to healthy adult volunteers
Christine Y Yu, Stuart E Campbell, Craig A Sponseller, et al.
Cureus
|
April 27, 2026
Data and Safety Monitoring Board Best Practices in Clinical Trials
Gerald L Klein, Roger E Morgan, Melissa Palmer, et al.
Current Medical Research and Opinion
|
December 14, 2011
Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin
Christine Y Yu, Stuart E Campbell, Baojin Zhu, et al.
Journal of Alzheimer'S Disease : JAD
|
April 3, 2026
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
Everard G B Vijverberg, Douglas W Scharre, Michael Woodward, et al.
Cureus
|
October 17, 2025
The Essential Role of Medical Monitors in Clinical Trials
Gerald L Klein, Elizabeth Barabash, Roger E Morgan, et al.
Page
of 1